Atlas Trials

Phase 2 Study With SNF472 in Calciphylaxis Patients

Clinical trial NCT02790073 · COMPLETED

Trial details

NCT number
NCT02790073
Sponsor
Sanifit Therapeutics S. A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
CalciphylaxisCalcific Uremic Arteriolopathy
Start date
2016-05-01
Primary completion
2017-11-15
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.